lunes, 2 de abril de 2018

Cervical Cancer Screening (PDQ®)—Health Professional Version - National Cancer Institute

Cervical Cancer Screening (PDQ®)—Health Professional Version - National Cancer Institute

National Cancer Institute



Cervical Cancer Screening (PDQ®)–Health Professional Version









    SECTIONS



    Changes to This Summary (03/29/2018)

    Added Wright et al. as reference 4.
    Updated statistics with estimated new cases and deaths for 2018 (cited American Cancer Society as reference 1). Also revised text to state that from 2005 to 2014, overall incidence rates stabilized, and from 2006 to 2015, the death rate decreased by 0.8% per year.
    Added Halfon et al. as reference 45.
    The Alternative Screening and Treatment Strategies Including Low-Resource Settingssubsection was renamed from Alternative Screening and Treatment Strategies in Low-resource Settings.
    Added text to state that a Dutch study among women who participated in the national cervical cancer screening program found that vaginal self-sampling was highly concordant with high-risk human papilloma virus prevalence in physician-collected samples and was both convenient and user friendly; also added that vaginal self-sampling will be offered in the Dutch national screening program for those who do not participate in their routine screening (cited Ketelaars et al. as reference 78).
    Added Raffle et al. as reference 4.
    This summary is written and maintained by the PDQ Screening and Prevention Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
    • Updated: March 29, 2018

    No hay comentarios:

    Publicar un comentario